English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 小时
Weight loss drug approved to treat sleep apnea
Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...
10 小时
on MSN
Medicare Part D to Cover Zepbound
Medicare Part D plans cover popular obesity drugs if they are used for an additional medically accepted purpose as approved ...
9 小时
Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price ...
Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.
Purdue Exponent
4 小时
Purdue, Lilly and Merck launch new manufacturing collaboration effort
Medical industry giants Eli Lilly and Merck will collaborate with Purdue through a new institute, which aims to advance ...
11 小时
Piper Sandler Keeps Their Buy Rating on Inspire Medical Systems (INSP)
Piper Sandler analyst Adam Maeder maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) today and set a price target of ...
11 小时
RBC Capital Sticks to Their Buy Rating for Inspire Medical Systems (INSP)
RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...
Investor's Business Daily on MSN
3 小时
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈